{'fraction_non_alphanumeric': 0.03262642740619902, 'fraction_numerical': 0.005709624796084829, 'mean_word_length': 4.854415274463007, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Abstract 234: Identification of a Novel Cardiomyocyte-enriched Long Noncoding Rna Counteracting Against Heart Failure Development


 Background:
 The number of patients with heart failure (HF) continues to increase as the elderly population grows, and mortality remains high, with about 50% of HF patients dying within 5 years of diagnosis. Therefore, defining molecular mechanisms underlying HF pathologies is urgently needed.
 
 
 Methods and Results:
 Using a gene trapping approach in mouse ES cells, we identified
 Caren
 (for
 
 car
 
 diomyocyte-
 
 en
 
 riched noncoding transcript), a novel cytoplasmic lncRNA abundantly expressed in cardiomyocytes.
 Caren
 expression in mice markedly decreased in heart failure (HF) induced by transverse aortic constriction (TAC), AngiotensinII loaded or aging.
 Caren
 ablation accelerated HF-related phenotypes, whereas
 Caren
 transgenic (Tg) mice in cardiomyocytes resisted TAC-induced HF. Furthermore,
 Caren
 overexpression in cardiomyocytes activated mitochondrial biogenesis and attenuated TAC-induced activation of Ataxia Telangiectasia Mutated (ATM) serine/threonine kinase, a regulator of the DNA damage response (DDR). Next, we generated Tg mice expressing
 Caren
 fragments (fragments A-E, from 5’ to 3’) respectively, by inserting that fragment into the corresponding endogenous
 Caren
 genomic locus. None of these Tg mice exhibited an anti-HF effect against TAC, suggesting that anti-HF effects of
 Caren
 may be more dependent on a structural motif displayed by the full-length lncRNA rather than on a specific
 Caren
 sequence. Consistently, restoration of expression of full-length
 Caren
 in TAC-induced failing cardiomyocytes slows HF progression in mice injected with AAV6-
 Caren
 . Mechanistically,
 Caren
 inhibited translation of mRNA encoding ‘
 Caren
 Target Protein 1’ (CTP1), which activates the ATM-DDR pathway and reduces mitochondrial respiratory capacity in cardiomyocytes. CTP1
 +/-
 mice resisted HF development, strongly suggesting that
 Caren
 protects against HF by suppressing CTP1 expression.
 
 
 Conclusion:
 This is the first study reporting that
 Caren
 , a novel cytoplasmic lncRNA
 ,
 counteracts HF development and progression by inactivating the ATM-DDR pathway and activating mitochondrial bioenergetics, in part, by suppressing CTP1 translation in cardiomyocytes. Our findings could encourage development of RNA-based strategies to combat HF development.
